DONNA BEARDEN: Open Payments
NPI 1245589514 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$990 in 33 payments from 19 companies in 2025. Trend: 2023 $753 · 2024 $1,393 · 2025 $990
Food & beverage: $990
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $293 |
| Organon LLC | 1 | $123 |
| GENZYME CORPORATION | 3 | $68 |
| PFIZER INC. | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| CSL Behring | 2 | $50 |
| Optinose US, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Novo Nordisk Inc | 2 | $43 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
Products named: FASENRA, VTAMA, DUPIXENT, Haegarda, Xhance, Rybelsus, PANZYGA, TEZSPIRE.
Industry payments across TN — which companies pay providers there.
